Related Experiment Video

Updated: Jun 25, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia

Natalia L Komarova1, Allen A Katouli, Dominik Wodarz

  • 1Department of Mathematics, University of California Irvine, Irvine, California, USA.

Plos One
|February 11, 2009
PubMed

Insights

Combining two targeted drugs, like Imatinib, Dasatinib, and Nilotinib, can improve chronic myeloid leukemia (CML) treatment success and prevent drug resistance. Computational analysis shows that two-drug combinations are optimal, avoiding resistance mutations like T315I.

Area of Science:

  • Hematology
  • Oncology
  • Computational Biology

Background:

  • Chronic myeloid leukemia (CML) is a hematopoietic cancer treated with Imatinib.
  • Drug resistance, often due to mutations, limits treatment efficacy.
  • Dasatinib and Nilotinib are alternatives that can be combined with Imatinib.

Purpose of the Study:

  • To investigate optimal drug combination strategies for preventing resistance in CML treatment.
  • To evaluate the efficacy of combining targeted therapies, including those with cross-resistance potential.

Main Methods:

  • Utilized computational methods to model drug interactions and resistance.
  • Analyzed mutation profiles, including the T315I mutation, conferring resistance to multiple drugs.
  • Explored combinations of existing and investigational drugs for CML.

Main Results:

  • Drug combinations significantly increase the probability of successful CML treatment.
  • Combining two drugs is more effective than using single agents or more than two.
  • The T315I mutation confers resistance to Imatinib, Dasatinib, and Nilotinib, but two-drug combinations can overcome this.

Conclusions:

  • Optimal CML therapy involves combining the two most effective targeted drugs to prevent resistance.
  • More than two drugs do not offer additional benefits and may not be necessary.
  • Strategic drug combinations are crucial for overcoming resistance in CML management.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...